We only have this paper's title and publication details.
Read it at the sourceGenetic analysis reveals KSR2 as an oncogenic driver in TAL1-subtype T-cell acute lymphoblastic leukemia, highlighting its clinical and prognostic relevance.
No takes yet. Share an insight, caveat, or question.
Drobna‐Śledzińska et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: